Progesterone For The Prevention Of Preterm Birth

Patent No. EP2117554 (titled "Progesterone For The Prevention Of Preterm Birth") was filed by Allergan Sales on Feb 5, 2008. The application was issued on Jul 13, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BESINS HEALTHCARE MONACO S.A.MApr 13, 2017NEDERLANDSCH OCTROOIBUREAU
FERRINGApr 7, 2017HOYNG ROKH MONEGIER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2117554

ALLERGAN SALES
Application Number
EP08702057A
Filing Date
Feb 5, 2008
Status
Revoked
May 31, 2024
Publication Date
Jul 13, 2016